DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 990 filers reported holding DANAHER CORPORATION in Q3 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,549,000 | -78.1% | 18,100 | -80.1% | 0.05% | -69.3% |
| Q4 2016 | $7,084,000 | -12.8% | 91,000 | -12.2% | 0.17% | 0.0% |
| Q3 2016 | $8,121,000 | -6.7% | 103,600 | +20.2% | 0.17% | +11.4% |
| Q2 2016 | $8,706,000 | +24.7% | 86,200 | +17.1% | 0.15% | +21.1% |
| Q1 2016 | $6,984,000 | -89.5% | 73,630 | -89.7% | 0.12% | -82.1% |
| Q4 2015 | $66,253,000 | +156.4% | 713,323 | +135.2% | 0.69% | +178.9% |
| Q3 2015 | $25,840,000 | -33.7% | 303,260 | -33.4% | 0.25% | -30.8% |
| Q2 2015 | $38,985,000 | +31.0% | 455,485 | +29.9% | 0.36% | +20.6% |
| Q1 2015 | $29,767,000 | -30.4% | 350,620 | -29.8% | 0.30% | +10.0% |
| Q4 2014 | $42,787,000 | -11.4% | 499,215 | -21.5% | 0.27% | +12.6% |
| Q3 2014 | $48,300,000 | +373.0% | 635,700 | +390.1% | 0.24% | +387.8% |
| Q2 2014 | $10,212,000 | +30.3% | 129,707 | +24.1% | 0.05% | +11.4% |
| Q1 2014 | $7,838,000 | -78.5% | 104,500 | -77.9% | 0.04% | -77.6% |
| Q4 2013 | $36,526,000 | +264.2% | 473,139 | +227.1% | 0.20% | +216.1% |
| Q3 2013 | $10,028,000 | -31.3% | 144,655 | -37.2% | 0.06% | -30.3% |
| Q2 2013 | $14,592,000 | – | 230,524 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |